<?xml version="1.0" encoding="UTF-8"?>
<p>Inflammation plays a key role in many human diseases. Recent studies show that many noncommunicable diseases share common pathophysiological mechanisms, where oxidative stress and inflammation play a major role in the onset and development of these diseases (
 <xref rid="B35" ref-type="bibr">Camps and García-Heredia, 2014</xref>). Inflammation has been related to obesity, diabetes, cancer, cardiovascular diseases, among others, through various mechanisms (
 <xref rid="B63" ref-type="bibr">Ghosh et al., 2015</xref>). Thus, many investigations have focused on the antiinflammatory pharmaceutical potential of phytochemicals and natural products, aiming to ameliorate adverse effects from antiinflammatory drugs (
 <xref rid="B14" ref-type="bibr">Ambriz-Pérez et al., 2016</xref>). In this sense, some 
 <italic>Terminalia</italic> species have been reported with antiinflammatory activity 
 <italic>in vitro</italic>, which is regularly attributed to their phytochemical composition; the association between the antiinflammatory activity and the structural characteristics of some phytochemicals has already been reported (
 <xref rid="B59" ref-type="bibr">Gautam and Jachak, 2009</xref>; 
 <xref rid="B92" ref-type="bibr">Lago et al., 2014</xref>). In this section, we summarize some of the most recent reports on the antiinflammatory potential of 
 <italic>Terminalia</italic> species.
</p>
